Business Description
Stevanato Group SpA
ISIN : IT0005452658
Total Employee Number:
5,795Description
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.29 | |||||
Debt-to-EBITDA | 1.78 | |||||
Interest Coverage | 28.23 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.14 | |||||
Beneish M-Score | -2.61 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.9 | |||||
3-Year EBITDA Growth Rate | 5.9 | |||||
3-Year EPS without NRI Growth Rate | 2.1 | |||||
3-Year Book Growth Rate | 17 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 18.65 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.71 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 22.38 | |||||
9-Day RSI | 33.07 | |||||
14-Day RSI | 41.48 | |||||
3-1 Month Momentum % | 10.83 | |||||
6-1 Month Momentum % | 31.82 | |||||
12-1 Month Momentum % | -18.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.61 | |||||
Quick Ratio | 1.08 | |||||
Cash Ratio | 0.14 | |||||
Days Inventory | 119.21 | |||||
Days Sales Outstanding | 82.69 | |||||
Days Payable | 101.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.31 | |||||
Dividend Payout Ratio | 0.1 | |||||
3-Year Dividend Growth Rate | 5.3 | |||||
Forward Dividend Yield % | 0.31 | |||||
5-Year Yield-on-Cost % | 0.31 | |||||
3-Year Average Share Buyback Ratio | -1 | |||||
Shareholder Yield % | -1.27 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 29.18 | |||||
Operating Margin % | 17.39 | |||||
Net Margin % | 11 | |||||
EBITDA Margin % | 20.13 | |||||
FCF Margin % | -2.51 | |||||
OCF Margin % | 20.3 | |||||
ROE % | 9.12 | |||||
ROA % | 5.4 | |||||
ROIC % | 7.11 | |||||
3-Year ROIIC % | 1.3 | |||||
ROC (Joel Greenblatt) % | 12.98 | |||||
ROCE % | 10.13 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 36.29 | |||||
Forward PE Ratio | 23.67 | |||||
PE Ratio without NRI | 30.88 | |||||
Price-to-Owner-Earnings | 270.93 | |||||
PEG Ratio | 3.36 | |||||
PS Ratio | 3.89 | |||||
PB Ratio | 3.11 | |||||
Price-to-Tangible-Book | 3.3 | |||||
Price-to-Operating-Cash-Flow | 19.15 | |||||
EV-to-EBIT | 25.65 | |||||
EV-to-Forward-EBIT | 22.02 | |||||
EV-to-EBITDA | 20.79 | |||||
EV-to-Forward-EBITDA | 15.3 | |||||
EV-to-Revenue | 4.19 | |||||
EV-to-Forward-Revenue | 4.29 | |||||
EV-to-FCF | -168.39 | |||||
Price-to-GF-Value | 0.78 | |||||
Price-to-Projected-FCF | 18.32 | |||||
Price-to-Graham-Number | 2.13 | |||||
Earnings Yield (Greenblatt) % | 3.9 | |||||
FCF Yield % | -0.64 | |||||
Forward Rate of Return (Yacktman) % | 2.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Stevanato Group SpA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,225.252 | ||
| EPS (TTM) (€) | 0.48 | ||
| Beta | -0.0028 | ||
| 3-Year Sharpe Ratio | -0.3 | ||
| 3-Year Sortino Ratio | -0.38 | ||
| Volatility % | 43.81 | ||
| 14-Day RSI | 41.48 | ||
| 14-Day ATR (€) | 0.495346 | ||
| 20-Day SMA (€) | 18.34 | ||
| 12-1 Month Momentum % | -18.69 | ||
| 52-Week Range (€) | 11.3 - 23.6 | ||
| Shares Outstanding (Mil) | 273.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Stevanato Group SpA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Stevanato Group SpA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-03-04 08:30 | In 177 days | ||
| Fourth quarter earnings results for 2026 | 2027-03-04 06:30 | In 177 days | ||
| Annual report for 2026 | 2027-03-04 | In 176 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-06 08:30 | In 59 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 06:30 | In 59 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 08:30 | 17.80 (+4.09%) | ||
| Second quarter earnings results for 2026 | 2026-08-04 06:30 | 17.80 (+4.09%) | ||
| EUR 0.054000 Cash Dividend | 2026-06-11 | 15.00 (-2.60%) | ||
| Jefferies Global Healthcare Conference in New York | 2026-06-04 09:55 | 16.00 (+0.63%) | ||
| William Blair 46th Annual Growth Stock Conference | 2026-06-02 14:40 | 16.00 (+1.27%) |
Show
Entries
Stevanato Group SpA Frequently Asked Questions
What is Stevanato Group SpA(FRA:87N)'s stock price today?
The current price of FRA:87N is €17.40. The 52 week high of FRA:87N is €23.60 and 52 week low is €11.30.
When is next earnings date of Stevanato Group SpA(FRA:87N)?
The next earnings date of Stevanato Group SpA(FRA:87N) is 2026-11-06 Est..
Does Stevanato Group SpA(FRA:87N) pay dividends? If so, how much?
The Dividend Yield %  of Stevanato Group SpA(FRA:87N) is 0.31% (As of Today), Highest Dividend Payout Ratio of Stevanato Group SpA(FRA:87N) was 0.11. The lowest was 0.09. And the median was 0.1. The  Forward Dividend Yield % of Stevanato Group SpA(FRA:87N) is 0.31%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Stevanato Group SpA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers